Effectiveness of mRNA COVID-19 Vaccines in Japan during the Nationwide Pandemic of the Delta Variant-Reference-Cited by-同舟云学术

Effectiveness of mRNA COVID-19 Vaccines in Japan during the Nationwide Pandemic of the Delta Variant

Published:2022 Issue:1 Volume:257 Page:1-6
ISSN:0040-8727
Container-title:The Tohoku Journal of Experimental Medicine
language:en
Short-container-title:Tohoku J. Exp. Med.

Author:

Akaishi Tetsuya¹,Kushimoto Shigeki²,Katori Yukio³,Sugawara Noriko⁴,Igarashi Kaoru⁵,Fujita Motoo⁶,Kure Shigeo⁴,Takayama Shin¹,Abe Michiaki¹,Kikuchi Akiko¹,Ishizawa Kota¹,Abe Yoshiko¹,Imai Hiroyuki⁷,Inaba Yohei⁸,Iwamatsu-Kobayashi Yoko⁹,Nishioka Takashi¹⁰,Onodera Ko¹,Ishii Tadashi¹

Affiliation:

1. Department of Education and Support for Regional Medicine, Tohoku University Hospital

2. Division of Emergency and Critical Care Medicine, Tohoku University Graduate School of Medicine

3. Department of Otolaryngology-Head and Neck Surgery, Tohoku University Graduate School of Medicine

4. Department of Pediatrics, Tohoku University Graduate School of Medicine

5. Division of Craniofacial Anomalies, Tohoku University Graduate School of Dentistry

6. Department of Emergency and Critical Care Medicine, Tohoku University Hospital

7. Clinical Skills Laboratory, Tohoku University School of Medicine

8. Department of Radiation Disaster Medicine, International Research Institute of Disaster Science, Tohoku University

9. Department of Dental Infection Control, Tohoku University Hospital

10. Liaison Center for Innovative Dentistry, Tohoku University Graduate School of Dentistry

Publisher

Tohoku University Medical Press

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.jstage.jst.go.jp/article/tjem/257/1/257_2022.J012/_pdf

Reference12 articles.

1. Bian, L., Gao, Q., Gao, F., Wang, Q., He, Q., Wu, X., Mao, Q., Xu, M. & Liang, Z.(2021) Impact of the Delta variant on vaccine efficacy and response strategies. Expert Rev. Vaccines, 20, 1201-1209.

2. Del Rio, C., Malani, P.N. & Omer, S.B.(2021) Confronting the Delta variant of SARS-CoV-2, summer 2021. JAMA, 326, 1001-1002.

3. Fontanet, A., Autran, B., Lina, B., Kieny, M.P., Karim, S.S.A. & Sridhar, D.(2021) SARS-CoV-2 variants and ending the COVID-19 pandemic. Lancet, 397, 952-954.

4. Ishii, T., Kushimoto, S., Katori, Y., Kure, S., Igarashi, K., Fujita, M., Takayama, S., Abe, M., Tanaka, J., Kikuchi, A., Abe, Y., Imai, H., Inaba, Y., Iwamatsu-Kobayashi, Y., Nishioka, T., et al.(2021) Predictors of SARS-CoV-2 positivity based on RT-PCR swab tests at a drive-through outpatient clinic for COVID-19 screening in Japan. Tohoku J. Exp. Med., 253, 101-108.

5. Lauer, S.A., Grantz, K.H., Bi, Q., Jones, F.K., Zheng, Q., Meredith, H.R., Azman, A.S., Reich, N.G. & Lessler, J.(2020) The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann. Intern. Med., 172, 577-582.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contribution of traditional Japanese Kampo medicines, kakkonto with shosaikotokakikyosekko, in treating patients with mild-to-moderate coronavirus disease 2019: Further analysis of a multicenter, randomized controlled trial;Journal of Infection and Chemotherapy;2023-11

2. Combined Impact of Omicron Vaccination and Environmental Risk Exposure: A Thailand Case Study;Vaccines;2023-01-29

3. Acute Adverse Events at a Mass Vaccination Site after the Third and Fourth COVID-19 Vaccinations in Japan;The Tohoku Journal of Experimental Medicine;2023

4. Reports of acute adverse events in mRNA COVID-19 vaccine recipients after the first and second doses in Japan;Scientific Reports;2022-09-15

5. Effectiveness of third vaccine dose for coronavirus disease 2019 during the Omicron variant pandemic: a prospective observational study in Japan;Scientific Reports;2022-08-10